Published in Obesity and Diabetes Week, September 14th, 2009
Annual reconstitution of Russell's U.S. indexes captures the 4,000 largest U.S. stocks, ranking them by total market capitalization. EnteroMedics' membership in the Russell 3000 is effective for one year and results in automatic inclusion in the small-cap Russell 2000 Index as well as relevant growth and value indexes. An industry-leading $4 trillion in assets are currently benchmarked to the Russell indexes.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.